Day: January 29, 2025
Precision BioSciences Strengthens Senior Leadership Team to Drive Multiple In Vivo Gene Editing Programs
- Cindy Atwell , promoted to Chief Development and Business Officer- - Cassie Gorsuch , PhD, promoted to Chief Scientific Officer – DURHAM, N.C. --(BUSINESS WIRE)--Jan. 29, 2025-- Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS